Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 59 min ago
Peer-reviewedCC BYResearch and practice in thrombosis and haemostasis

Mouse models to study von Willebrand factor in thrombosis: a scoping review

  • Veronica DeYoung1
  • Hassan Masood1
  • Peter Andrisani1
  • Arthane Kodeeswaran1
  • Taylor Sparring1
  • Jaskirat Arora1
  • Natasha Savic2
  • Jonathan L. Babulic2
  • Patricia C. Liaw1
  • Davide Matino1
  • Alison Fox-Robichaud1
  • Colin A. Kretz1
  1. 1Thrombosis and Atherosclerosis Research Institute (TaARI), Hamilton, Canada
  2. 2Department of Medicine, Queen’s University, Kingston, Canada
Read full textPDFCite

Related

  1. Beyond thrombosis: a scoping review of patient-reported outcomes in antiphospholipid syndrome
    Chanakya Nayudu, Andrew Song, Shruti Chaturvedi
    Blood vessels, thrombosis & hemostasisPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Von Willebrand factor A2 domain inhibits A1-DNA binding while preserving A1-platelet interaction under flow: evidence from recombinant domain constructs
    Zhitong Peng, Xiaoxi Sun, Guangzhou Qu +7
    Research and Practice in Thrombosis and HaemostasisPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  3. CO058 | ELEVATED PLASMA LEVELS OF OMEGA-3 STEARIDONIC ACID ARE ASSOCIATED WITH DECREASED FACTOR VIII COAGULANT ACTIVITY INDEPENDENTLY OF FACTOR VIII ANTIGEN AND VON WILLEBRAND FACTOR LEVELS: PRELIMINARY RESULTS FROM AN ANGIOGRAPHICALLY-CONTROLLED CARDIOVASCULAR COHORT STUDY
    Nicola Osti
    Bleeding, Thrombosis and Vascular BiologyPeer-reviewedCC BY-NCFull textCardiovascular medicineDOAJ
  4. von Willebrand Factor and ADAMTS13 Predict Therapeutic Efficacy and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Atezolizumab-Bevacizumab.
    Naoki Nishimura, Hiroaki Takaya, Tadashi Namisaki +10
    JGH open : an open access journal of gastroenterology and hepatologyPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  5. A screening assay for type 2B von Willebrand factor variants using an enzyme-linked immunosorbent assay based on recombinant wild-type glycoprotein Ib and ristocetin.
    Maria Teresa Pagliari, Luciano Baronciani, Paola Colpani +5
    Research and practice in thrombosis and haemostasisPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{deyoung2026mouse,
  title = {{Mouse models to study von Willebrand factor in thrombosis: a scoping review}},
  author = {Veronica DeYoung and Hassan Masood and Peter Andrisani and Arthane Kodeeswaran and Taylor Sparring and Jaskirat Arora and Natasha Savic and Jonathan L. Babulic and Patricia C. Liaw and Davide Matino and Alison Fox-Robichaud and Colin A. Kretz},
  journal = {Research and practice in thrombosis and haemostasis},
  year = {2026},
  month = jul,
  url = {https://europepmc.org/article/PMC/PMC13675921},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Mouse models to study von Willebrand factor in thrombosis: a scoping review
AU  - Veronica DeYoung
AU  - Hassan Masood
AU  - Peter Andrisani
AU  - Arthane Kodeeswaran
AU  - Taylor Sparring
AU  - Jaskirat Arora
AU  - Natasha Savic
AU  - Jonathan L. Babulic
AU  - Patricia C. Liaw
AU  - Davide Matino
AU  - Alison Fox-Robichaud
AU  - Colin A. Kretz
PY  - 2026
DA  - 2026/07/15
JO  - Research and practice in thrombosis and haemostasis
UR  - https://europepmc.org/article/PMC/PMC13675921
SN  - 2475-0379
ER  -